Edition:
United Kingdom

Ben Hirschler

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

21 Jul 2017

GlaxoSmithKline's new CEO prepares to trim drug pipeline

LONDON GlaxoSmithKline's new chief executive, who has already made her mark with plans to divest some nutritional products, will turn next week to the main business of focussing the company's pipeline of new drugs.

21 Jul 2017

AstraZeneca CEO reassures staff, aims to be at September cancer meet

LONDON AstraZeneca Chief Executive Pascal Soriot, responding to rumors he might leave the drugmaker to join rival Teva Pharmaceutical Industries, has told staff he expects to work together with employees to see the company succeed.

19 Jul 2017

GSK puts old antibiotics and UK Horlicks business on the block

LONDON GlaxoSmithKline said it was considering the sale of its cephalosporins antibiotics business and intended to divest its small Horlicks business in Britain, while retaining the much bigger malted drink operation in India.

19 Jul 2017

EU watchdog concerned drug agency EMA may be too close to companies

LONDON The European Medicines Agency (EMA), eager to accelerate access to promising new drugs, may be getting too cosy with the pharmaceutical companies it regulates.

06 Jul 2017

Robot wars: knee surgery marks new battleground for companies

LONDON The world's top medical technology companies are turning to robots to help with complex knee surgery, promising quicker procedures and better results in operations that often leave patients dissatisfied. | Video

06 Jul 2017

Robot wars: knee surgery marks new battleground for companies

LONDON The world's top medical technology companies are turning to robots to help with complex knee surgery, promising quicker procedures and better results in operations that often leave patients dissatisfied. | Video

05 Jul 2017

Personalised vaccines hold cancer at bay in two early trials

LONDON A novel class of personalised cancer vaccines, tailored to the tumours of individual patients, kept disease in check in two early-stage clinical trials, pointing to a new way to help the immune system fight back.

05 Jul 2017

Personalized vaccines hold cancer at bay in two early trials

A novel class of personalized cancer vaccines, tailored to the tumors of individual patients, kept disease in check in two early-stage clinical trials, pointing to a new way to help the immune system fight back.

03 Jul 2017

Drugmaker Shire faces blood and guts battles on road to growth

LONDON Shire has come a long way since 1986, from selling calcium supplements from above a shop in southern England to becoming a poster child for a nimble global drugs firm, driven by deals and smart bets on speciality medicines.

02 Jul 2017

Big pharma turns to AI to speed drug discovery, GSK signs deal

LONDON The world's leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with GlaxoSmithKline unveiling a new $43 million deal in the field on Sunday.

  • Europe
  • U.S.
  • Asia
  • Sectors
Stock Search
FTSE 100 7,452.91 -34.96 -0.47%
DAX 12,240.06 -207.19 -1.66%
CAC 40 5,117.66 -81.56 -1.57%
TR Europe 177.67 -1.43 -0.80%
GBP/USD 1.3006 +0.11%
GBP/EUR 1.1145 +0.13%
EUR/USD 1.1669 +0.07%
Gold 1,256.00 +1.70 +0.14%
Oil 45.67 -0.10 -0.22%
Corn 371.75 -8.00 -2.11%